Cargando…

Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience

BACKGROUND: Vascularized composite allotransplantation is constrained by complications associated with standard immunosuppressive strategies. Vascularized thymus and bone marrow have been shown to promote prolonged graft survival in composite organ and soft-tissue vascularized composite allotranspla...

Descripción completa

Detalles Bibliográficos
Autores principales: Sendil, Selin, Diaconu, Silviu C., O’Neill, Natalie A., Burdorf, Lars, Tatarov, Ivan, Parsell, Dawn M., Azimzadeh, Agnes M., Pierson, Richard N., Nam, Arthur J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889452/
https://www.ncbi.nlm.nih.gov/pubmed/29632759
http://dx.doi.org/10.1097/GOX.0000000000001538
_version_ 1783312697845088256
author Sendil, Selin
Diaconu, Silviu C.
O’Neill, Natalie A.
Burdorf, Lars
Tatarov, Ivan
Parsell, Dawn M.
Azimzadeh, Agnes M.
Pierson, Richard N.
Nam, Arthur J.
author_facet Sendil, Selin
Diaconu, Silviu C.
O’Neill, Natalie A.
Burdorf, Lars
Tatarov, Ivan
Parsell, Dawn M.
Azimzadeh, Agnes M.
Pierson, Richard N.
Nam, Arthur J.
author_sort Sendil, Selin
collection PubMed
description BACKGROUND: Vascularized composite allotransplantation is constrained by complications associated with standard immunosuppressive strategies. Vascularized thymus and bone marrow have been shown to promote prolonged graft survival in composite organ and soft-tissue vascularized composite allotransplantation models. We report development of a nonhuman primate vascularized thymosternal composite tissue transplant model as a platform to address donor-specific immune tolerance induction strategies. METHODS: Vascularized thymosternal allograft (skin, muscle, thymus, sternal bone) was transplanted between MHC-mismatched rhesus monkeys (feasibility studies) and baboons (long-term survival studies), with end-to-side anastomoses of the donor aorta and SVC to the recipient common femoral vessels. A male allograft was transplanted to a female’s lower abdominal wall, and clinically applicable immunosuppression was given. Skin biopsies and immunological assays were completed at regular intervals, and chimerism was quantified using polymerase chain reaction specific for baboon Y chromosome. RESULTS: Four allo- and 2 xenotransplants were performed, demonstrating consistent technical feasibility. In 1 baboon thymosternal allograft recipient treated with anti-CD40–based immunosuppression, loss of peripheral blood microchimerism after day 5 was observed and anticipated graft rejection at 13 days. In the second allograft, when cutaneous erythema and ecchymosis with allograft swelling was treated with anti-thymocyte globulin starting on day 6, microchimerism persisted until immunosuppression was reduced after the first month, and the allograft survived to 87 days, 1 month after cessation of immunosuppression treatment. CONCLUSIONS: We established both allo- and xeno- composite vascularized thymosternal transplant preclinical models, which will be useful to investigate the role of primarily vascularized donor bone marrow and thymus.
format Online
Article
Text
id pubmed-5889452
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-58894522018-04-09 Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience Sendil, Selin Diaconu, Silviu C. O’Neill, Natalie A. Burdorf, Lars Tatarov, Ivan Parsell, Dawn M. Azimzadeh, Agnes M. Pierson, Richard N. Nam, Arthur J. Plast Reconstr Surg Glob Open Experimental BACKGROUND: Vascularized composite allotransplantation is constrained by complications associated with standard immunosuppressive strategies. Vascularized thymus and bone marrow have been shown to promote prolonged graft survival in composite organ and soft-tissue vascularized composite allotransplantation models. We report development of a nonhuman primate vascularized thymosternal composite tissue transplant model as a platform to address donor-specific immune tolerance induction strategies. METHODS: Vascularized thymosternal allograft (skin, muscle, thymus, sternal bone) was transplanted between MHC-mismatched rhesus monkeys (feasibility studies) and baboons (long-term survival studies), with end-to-side anastomoses of the donor aorta and SVC to the recipient common femoral vessels. A male allograft was transplanted to a female’s lower abdominal wall, and clinically applicable immunosuppression was given. Skin biopsies and immunological assays were completed at regular intervals, and chimerism was quantified using polymerase chain reaction specific for baboon Y chromosome. RESULTS: Four allo- and 2 xenotransplants were performed, demonstrating consistent technical feasibility. In 1 baboon thymosternal allograft recipient treated with anti-CD40–based immunosuppression, loss of peripheral blood microchimerism after day 5 was observed and anticipated graft rejection at 13 days. In the second allograft, when cutaneous erythema and ecchymosis with allograft swelling was treated with anti-thymocyte globulin starting on day 6, microchimerism persisted until immunosuppression was reduced after the first month, and the allograft survived to 87 days, 1 month after cessation of immunosuppression treatment. CONCLUSIONS: We established both allo- and xeno- composite vascularized thymosternal transplant preclinical models, which will be useful to investigate the role of primarily vascularized donor bone marrow and thymus. Wolters Kluwer Health 2017-12-22 /pmc/articles/PMC5889452/ /pubmed/29632759 http://dx.doi.org/10.1097/GOX.0000000000001538 Text en Copyright © 2017 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Experimental
Sendil, Selin
Diaconu, Silviu C.
O’Neill, Natalie A.
Burdorf, Lars
Tatarov, Ivan
Parsell, Dawn M.
Azimzadeh, Agnes M.
Pierson, Richard N.
Nam, Arthur J.
Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience
title Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience
title_full Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience
title_fullStr Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience
title_full_unstemmed Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience
title_short Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience
title_sort vascularized thymosternal composite tissue allo- and xenotransplantation in nonhuman primates: initial experience
topic Experimental
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889452/
https://www.ncbi.nlm.nih.gov/pubmed/29632759
http://dx.doi.org/10.1097/GOX.0000000000001538
work_keys_str_mv AT sendilselin vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience
AT diaconusilviuc vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience
AT oneillnataliea vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience
AT burdorflars vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience
AT tatarovivan vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience
AT parselldawnm vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience
AT azimzadehagnesm vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience
AT piersonrichardn vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience
AT namarthurj vascularizedthymosternalcompositetissuealloandxenotransplantationinnonhumanprimatesinitialexperience